Skip to content

Clinical trials

Approved for marketing trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Status: Approved for marketing Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Pfizer2
Tibotec Pharmaceuticals, Ireland2
AstraZeneca1
BioMarin Pharmaceutical1
Gilead Sciences1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
COVID-191
Carcinoma, Medullary1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Gastrointestinal Neoplasms1
HIV Infections1
Head and Neck Neoplasms1
Neoplasm Metastasis1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.